Atrovent Nasal Spray

Atrovent Nasal Spray is a brand of medicine containing the active ingredient ipratropium bromide (nose medicines (topical)).

Find out more about active ingredients.

Consumer medicine information (CMI) leaflet

Developed by the pharmaceutical company responsible for this medicine in Australia, according to TGA regulations.

Atrovent® Nasal

Ipratropium bromide

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about Atrovent Nasal.

It does not contain all available information.

It does not take the place of talking to your doctor or pharmacist.

This leaflet was last updated on the date at the end of this leaflet. More recent information may be available. The latest Consumer Medicine Information is available from your pharmacist, doctor, or from and may contain important information about the medicine and its use of which you should be aware.

Keep this information with your nasal spray.

You may need to read it again later.

Back to top

To find out more about Atrovent Nasal

You should ask your doctor or pharmacist if you have any questions about your medicine or if you have any trouble before, during or after using Atrovent Nasal.

Back to top

What Atrovent Nasal is used for

Atrovent Nasal relieves the symptoms of a persistent runny nose associated with allergic rhinitis (hayfever) and non-allergic non-seasonal rhinitis.

Atrovent Nasal relieves a runny nose by acting directly on the mucous glands of the nose to decrease watery secretions.

Atrovent Nasal is known as an anticholinergic medicine. It belongs to one of several types of medicines used to treat the symptoms of rhinitis.

Back to top

Before you use Atrovent Nasal

When not to use Atrovent Nasal

Do not use Atrovent Nasal if you are allergic to it or to any of the ingredients. These ingredients are listed in full at the end of this leaflet.

In some cases you should not use Atrovent Nasal if you are allergic to certain other medicines.

You must tell your doctor or pharmacist if you are allergic to any other medicine, particularly atropine or other anticholinergic medicines.

If you are uncertain as to whether you have these allergies you should raise those concerns with your doctor or pharmacist.

You should not use Atrovent Nasal if the packaging is torn or shows signs of tampering.

You should never use Atrovent Nasal after the EXPIRY DATE on the bottle or carton.

If you use it after the expiry date has passed, it may not work as well.

Before you start to use Atrovent Nasal

Before using Atrovent Nasal, you must tell your doctor or pharmacist if you have, or have had, any of the following conditions:

  • an eye problem called "glaucoma"
  • enlargement of the prostate gland
  • problems with passing urine
  • cystic fibrosis.

If you are uncertain as to whether you have, or have had, any of these conditions you should raise those concerns with your doctor or pharmacist.

Atrovent Nasal spray contains the (antimicrobial) preservative benzalkonium chloride which may cause irritation of the nasal lining (mucosa).

Before using Atrovent Nasal it is advisable to tell your doctor or pharmacist if you are taking any other medicines, obtained with or without a doctor's prescription, including medicines you buy from a pharmacy, supermarket or health food shop.

In particular, you should tell your doctor if you are taking any other medicine containing ipratropium bromide or another anticholinergic agent such as atropine, hyoscine or hyoscyamine.


Ask for your doctor's advice if you are pregnant, or likely to become pregnant during your course of medication.

Care is recommended during pregnancy, particularly in the first three months. The benefits of Atrovent Nasal must be assessed against any risks. Your doctor will discuss the risks and benefits of using Atrovent Nasal while you are pregnant.


Ask for your doctor's advice if you are breastfeeding or likely to breastfeed during the course of your medication.

Care is recommended if you are breastfeeding as it is not known if the active ingredient in Atrovent Nasal may pass into breast milk. The benefits of Atrovent Nasal must be assessed against any risks. Your doctor will discuss the risks and benefits of using Atrovent Nasal while you are breastfeeding.


There is not enough information available to recommend the use of Atrovent Nasal in children under 12 years of age.

Back to top

Using Atrovent Nasal

How to use Atrovent Nasal

At the end of this leaflet you will find directions on how to use Atrovent Nasal. Ask your doctor or pharmacist for advice if you have any problems with using this medicine.

Never spray Atrovent Nasal in or around your eyes.

If you accidentally spray Atrovent Nasal into your eyes, you may have temporary blurring of vision and increased sensitivity to light, lasting up to a few hours.

Contact your doctor immediately for advice as to what treatment is needed.

If you forget to take a dose

It is important to use Atrovent Nasal as directed.

If you miss a dose, take it as soon as you remember. However, if you remember when it is almost time for your next dose, take only your usual dose at that time.


Seek medical advice if you have used more than the recommended or prescribed dose of Atrovent Nasal.

Immediately telephone your doctor, pharmacist or the Poisons Information Centre (telephone 13 11 26 in Australia).

Do this even if there are no signs of discomfort or poisoning.

Signs of overdose may include increased heart rate, dry mouth, and blurred vision.

Back to top

While using Atrovent Nasal

Things you must do

Contact your doctor immediately if you experience eye pain or discomfort, or any disturbances with your sight (blurred vision, visual halos or coloured images) during or after using Atrovent Nasal.

If the spray from Atrovent Nasal comes into direct contact with the eyes, it may cause eye pain, blurring of vision and increased sensitivity to light.

It may also cause a more serious eye problem, known as glaucoma, to develop or worsen. The following symptoms may be associated with glaucoma: red eyes, eye pain or discomfort, sight disturbances (blurred vision, visual halos or coloured images).

Therefore, it is very important to follow the Directions For Use carefully and avoid contact with the eyes.

Tell your doctor or pharmacist if you begin taking any other medicine while you are using Atrovent Nasal.

If symptoms persist, seek medical advice.

Things you must not do

Do not use Atrovent Nasal when the medicine is running out and it is no longer possible to obtain a firm spray.

Ability to Drive or Operate Machinery

If side effects are experienced such as dizziness, blurred vision or dilated pupils (mydriasis) whilst using Atrovent Nasal sprays do not drive or operate machinery.

Back to top

Side effects

You should be aware that all medicines carry some risks and that all possible risks may not be known at this stage despite thorough testing.

Ask for the advice of your doctor or pharmacist if you have any concerns about the effects of using this medicine.

Adverse effects are usually mild to moderate and transient.

Reported side effects of Atrovent Nasal include:

  • dryness of the nose, nose bleeds, nasal irritation.
  • headache, nausea and local irritation (such as a burning sensation)
  • dry mouth, sore mouth and swelling of the mouth
  • sore throat, discomfort when swallowing (also known as pharyngitis), swelling of the throat and throat irritation (e.g. dry throat)
  • infections of the air passages.
  • eye disturbances such as red eyes, eye pain or discomfort, blurred vision, visual halos or coloured images, increased sensitivity to light
  • fast or irregular heart beat
  • change in bowel movements
  • urinary retention (difficulty passing urine).
  • allergic reactions such as skin rash, swelling of the tongue, lips and face, and difficulty breathing.
  • Serious allergic (anaphylactoid) reactions have also been reported.

Tell your doctor or pharmacist as soon as possible if you experience any side effects during or after using Atrovent Nasal, so that these may be properly treated.

In addition, unexpected effects, not listed above, can occur with any medicine.

You should tell your doctor or pharmacist if you notice anything unusual, during or after using Atrovent Nasal.

Back to top

After using Atrovent Nasal

Care and cleaning

It is recommended that the spray adaptor be cleaned after use.


Atrovent Nasal should be kept in a cool, dry place where the temperature stays below 25C.

Do not store in direct sunlight or heat and protect from freezing.

Keep Atrovent Nasal where young children cannot reach it.


If you will not be needing Atrovent Nasal anymore, the unused medicine should be returned to your pharmacist so that it can be disposed of safely.

Back to top

Product Description

What Atrovent Nasal is

Atrovent Nasal is the brand name of your medicine. It is a clear, colourless solution in amber glass bottles. Each bottle contains 15 mL of solution which provides at least 180 metered doses.

Atrovent Nasal is identified by an Australian Registration Number and this number appears on the pack (AUST R 53362). Ingredients

Each spray of Atrovent Nasal contains

22 micrograms of ipratropium bromide [equivalent to ipratropium bromide (anhydrous) 21 micrograms] in purified water.

Other ingredients include:

  • benzalkonium chloride as a preservative
  • disodium edetate
  • sodium chloride (salt)
  • sodium hydroxide
  • hydrochloric acid


Atrovent Nasal is made in Italy and supplied in Australia by:

( ABN 52 000 452 308)
78 Waterloo Road

This leaflet revised in July 2010.

Atrovent is a registered trade mark of Boehringer Ingelheim

© Boehringer Ingelheim Pty Limited 2010

Back to top

Atrovent® Nasal

Ipratropium bromide

Directions For Use

Important Information :

Read complete directions carefully and use only as directed.

Do not spray in or around your eyes.

Do not pierce the nozzle or attempt to enlarge the hole. The hole in the nozzle is a special size to allow the correct dose of Atrovent Nasal to enter your nostril when you depress the spray pump.

Do not shake the bottle.

To Use:

  1. Remove protective cap.
  2. Before using the spray pump for the first time, rapidly activate the spray pump 5 to 7 times until an even spray mist is released (see Figure 1). Your Atrovent Nasal is now primed and ready for use.

With subsequent use, the spray pump is immediately functional. However, if the spray pump has not been used for more than 24 hours, it will require repriming.
  1. Blow nose thoroughly before using the nasal spray.
  2. Keeping the bottle upright, insert the spray adaptor into the nostril and activate the spray pump firmly while breathing in gently through the nose (see Figure 2). Administer the number of sprays as recommended or as prescribed by your doctor or pharmacist and then repeat in the other nostril.

  1. Replace protective cap after use.
  2. Store upright
  3. To Clean:
If the nasal tip becomes clogged, remove protective cap. Hold the nasal tip under running, warm tap water (see Figure 3) for about a minute. Dry the nasal tip, reprime the nasal pump spray (step 2 above), and replace the protective cap.

Back to top

CMI provided by MIMS Australia, December 2014  

Related information - Atrovent Nasal Spray


02 Nov 2012 Find reliable, independent information about allergic inflammation of the nose. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.allergic inflammation of the nose is also known as allergic rhinitis.
29 Oct 2012 Information on medicines available in Australia containing ipratropium bromide (nose medicines (topical)), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain ipratropium bromide (nose medicines (topical)) below, including their consumer medicine information (CMI) leaflets.